Concepedia

Author

Kuniaki Itoh

National Cancer Center Hospital East

Also Known As

Hironobu Minami, Itoh, Itoh, K., K Itoh, K. ITOH, K. Itoh, KUNIAKI ITOH, Katsumi ITOH, Kuniaki ITOH, Kuniaki Itoh

220

Publications

2.9K

Citations

27

H-Index

99

Concepts

All Affiliations

National Cancer Center Hospital EastTokai UniversityAichi Cancer CenterNational Cancer CenterKobe University
KI

About

Kuniaki Itoh is an author at National Cancer Center Hospital East specializing in medicine, oncology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

18

24

784

2

Engineering

11

14

277

3

Natural Sciences

5

5

84

4

Health Sciences

4

4

144

5

Allergy

1

1

16

Kuniaki Itoh

×

64

Publications

2.5K

Citations

27

H-Index

YearCitations

Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211

Motoko Yamaguchi, Kensei Tobinai, Masahiko Oguchi,

Journal of Clinical Oncology

2009

336

Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study

Shigeru Kusumoto, Yasuhito Tanaka, Ritsuro Suzuki,

Clinical Infectious Diseases

2015

147

Genetic polymorphisms of CYP2B6 affect the pharmacokinetics/pharmacodynamics of cyclophosphamide in Japanese cancer patients

Miki Nakajima, Sayaka Komagata, Yuto Fujiki,

Pharmacogenetics and Genomics

2007

128

A multicentre phase <scp>II</scp> study of vorinostat in patients with relapsed or refractory indolent B‐cell non‐Hodgkin lymphoma and mantle cell lymphoma

Michinori Ogura, Kiyoshi Ando, Tatsuya Suzuki,

British Journal of Haematology

2014

110

Japanese multicenter phase II and pharmacokinetic study of rituximab in relapsed or refractory patients with aggressive B-cell lymphoma

Kensei Tobinai, Tomofumi Igarashi, Kuniaki Itoh,

Annals of Oncology

2004

104

β-barium borate single crystal grown by a direct Czochralski method

Kuniaki Itoh, F. Marumo, Yasuhiko Kuwano

Journal of Crystal Growth

1990

81

Indirect-response model for the time course of leukopenia with anticancer drugs*

Hironobu Minami, Yasutsuna Sasaki, Nagahiro Saijo,

Clinical Pharmacology & Therapeutics

1998

76

Multicenter phase II study of bendamustine for relapsed or refractory indolent B‐cell non‐Hodgkin lymphoma and mantle cell lymphoma

Ken Ohmachi, Kiyoshi Ando, Michinori Ogura,

Cancer Science

2010

67

Patients in phase I trials of anti-cancer agents in Japan: motivation, comprehension and expectations

Kuniaki Itoh, Yosuke Sasaki, Hirofumi Fujii,

British Journal of Cancer

1997

64

Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma

Yoshiaki Ogawa, Kensei Tobinai, Michinori Ogura,

Cancer Science

2007

63

Page 1